Strive Asset Management’s Abbott ABT Stock Holding History

Strive Asset Management’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,063	Closed	-$410K	–	2
2025 Q3	$410K	Sell	3,063 -409	-12%	-$53.7K	0.22%	46
2025 Q2	$472K	Sell	3,472 -2,269	-40%	-$299K	0.28%	48
2025 Q1	$762K	Sell	5,741 -545	-9%	-$69.4K	0.53%	45
2024 Q4	$711K	Buy	+6,286	New	+$726K	0.53%	49

Other funds holding ABT

JSC

J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Strive Asset Management's ABT Position: Q4 2025 in Review

Strive Asset Management sold out of Abbott (ABT) in Q4 2025, closing a stake of 3,063 shares — an estimated $410K sold.

Strive Asset Management first reported a position in ABT in Q4 2024 and held it in 4 quarters. The position peaked at $762K in Q1 2025. 3,275 funds tracked by Wall St. Rank hold ABT as of Q4 2025.

Strive Asset Management reported no remaining Abbott position as of Q4 2025 after selling out during the quarter.
Strive Asset Management sold 3,063 Abbott shares in Q4 2025, an estimated $410K.
Strive Asset Management first reported a position in Abbott in Q4 2024 and held it in 4 quarters.
Strive Asset Management's Abbott position peaked at $762K in Q1 2025.
3,275 funds tracked by Wall St. Rank held Abbott as of Q4 2025.

Based on Strive Asset Management's 13F filing for Q4 2025.